![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Liver Cirrhosis |
Free Subscription
2 Gastroenterology |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Liver Cirrhosis is free of charge.
Magnetically guided capsule endoscopy comparable to EGD for detecting
esophagogastric varices in patients with cirrhosis.
Gastroenterology. 2024 May 28:S0016-5085(24)05001.
PubMed
Portal Vein Thrombosis in the Setting of Cirrhosis: Evaluation and Management
Strategies.
Gastroenterology. 2024 May 25:S0016-5085(24)04951.
PubMed
TIPSS plus extrahepatic collateral embolisation may decrease variceal rebleeding
and post-TIPSS hepatic encephalopathy.
Gut. 2023 Jul 31:gutjnl-2023-330255. doi: 10.1136/gutjnl-2023-330255.
PubMed
Reply: Regarding the use of decision curve analysis in predicting long-term
complications of liver cirrhosis.
Hepatology. 2024 May 29. doi: 10.1097/HEP.0000000000000947.
PubMed
Identifying Predictors of Acute and Non-acute Decompensation in a Cohort of MASLD
Predominant Cirrhosis.
J Hepatol. 2024 May 24:S0168-8278(24)00363-5. doi: 10.1016/j.jhep.2024.
PubMed
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
Reply.
N Engl J Med. 2024;390:1935-1936.
PubMed
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
Reply.
N Engl J Med. 2024;390:1934-1935.
PubMed
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
N Engl J Med. 2024;390:1934.
PubMed
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
N Engl J Med. 2024;390:1933-1934.
PubMed
Thank you for your interest in scientific medicine.